Top

Cancer Chemotherapy and Pharmacology

Published in:

01-09-1997 | ORIGINAL ARTICLE

Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer

Published in: Cancer Chemotherapy and Pharmacology | Issue 6/1997

Title: Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer
Publication date: 01-09-1997
Published in: Cancer Chemotherapy and Pharmacology / Issue 6/1997
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/s002800050697

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 6/1997

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma

Pharmacokinetics of Adriamycin and cisplatin for anhepatic chemotherapy during liver transplantation

Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers

The effects of anesthesia on the biodistribution of drugs in rats: a carboplatin study

Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells

GS-164, a small synthetic compound, stimulates tubulin polymerization by a similar mechanism to that of Taxol

Keynote webinar | Spotlight on antibody–drug conjugates in cancer